Answers are grounded in this paper and cite their sources.
To some extent, the immunomodulation protocol used in our study reduced antibody titers, but it did not eliminate them. Overall, there have been few reports on secondary immunomodulation, and various protocols have been applied. Future research should seek to identify the most successful immunomodulation protocol in patients with high sustained titers.
No takes yet. Share an insight, caveat, or question.
Poelman et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: